PUBLIC CONTRACT · 2025
Fosaprepitant 150 mg Pó sol inj Fr IV CPA 2023/436 rutura
- Contract value
- €3,780.00
- Signed on
- 18 December 2025
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 12145588PUBLISHED SUBJECT
1837225 Fosaprepitant 150 mg Pó sol inj Fr IV CPA 2023/436 rutura
Parties involved
- Place of performance
- Portugal, Porto, Vila Nova de Gaia
- NUTS region
- PT11A - Área Metropolitana do Porto
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- HIKMA FARMACÊUTICA (PORTUGAL) SA. · Tax ID 502266791
Values and timeline
- Contract price
- €3,780.00
- Procedure base price
- €3,780.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 18 December 2025
- Award date
- 18 December 2025
- Signing date
- 18 December 2025
- Performance period
- 180 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- 436/2023 - Medicamentos para o sistema nervoso central
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 8191702
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.